Optimization of Microfluidizer-Produced PLGA Nano-Micelles for Enhanced Stability and Antioxidant Efficacy: A Quality by Design Approach
Esma Nur Develi Arslanhan, Fatemeh Bahadori, Zahra Eskandari, Muhammed Zahid Kasapoglu, Erkan Mankan

TL;DR
This study uses a design-based approach to optimize the production of stable nano-micelles for drug delivery, improving their long-term stability and scalability.
Contribution
A Quality by Design approach is applied to microfluidizer-based production of PLGA nano-micelles, enabling precise control and enhanced stability.
Findings
Optimized PMFZ parameters included 82.96 mg PLGA, 6.78 mL 5% T80, 11,000 psi pressure, and 1 pass.
Microfluidization under QbD guidance improved PLGANM stability and reproducibility compared to traditional methods.
Stability was evaluated over 60 days using size, polydispersity, and zeta potential measurements.
Abstract
Introduction: In this study, we aimed to optimize the microfluidizer-based preparation of poly(lactic-co-glycolic acid) nano-micelles (PLGANM), increasingly used for parenteral delivery of poorly water-soluble drugs but typically exhibiting poor physical stability when produced by conventional methods. Method: By systematically tuning microfluidization (MFZ) parameters, we demonstrate an efficient strategy to enhance PLGANM stability and ensure robust, scalable manufacturing, relevant for long-term storage and clinical translation applications. The influence of several key factors designed by Central Composite Design (CCD), including the amount of PLGA and Tween 80, homogenization pressure, and number of passes of MFZ on the size, polydispersity (measured by DLS), and hence stability of the PLGANM, was analyzed for 60 days. 60 PLGANMs produced by the MFZ method (PMFZ) were compared with…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems
